Analysis Shows Nearly 7% of Global Clinical Trials Are Impacted by Middle East Conflict - Takeaway - MDSpire

Analysis Shows Nearly 7% of Global Clinical Trials Are Impacted by Middle East Conflict

Oncology trials account for a substantial proportion of impacted activity, with non–small cell lung cancer representing the most affected indication, followed by breast cancer.

Share

Original Source(s)

Analysis Shows Nearly 7% of Global Clinical Trials Are Impacted by Middle East Conflict

  • by The ASCO Post Staff

  • April 7, 2026